HUE051902T2 - Duális újrafelvétel inhibitort tartamazó gyógyászati készítmény és eljárás annak elõállítására - Google Patents

Duális újrafelvétel inhibitort tartamazó gyógyászati készítmény és eljárás annak elõállítására

Info

Publication number
HUE051902T2
HUE051902T2 HUE14718330A HUE14718330A HUE051902T2 HU E051902 T2 HUE051902 T2 HU E051902T2 HU E14718330 A HUE14718330 A HU E14718330A HU E14718330 A HUE14718330 A HU E14718330A HU E051902 T2 HUE051902 T2 HU E051902T2
Authority
HU
Hungary
Prior art keywords
preparation
pharmaceutical composition
reuptake inhibitor
dual reuptake
dual
Prior art date
Application number
HUE14718330A
Other languages
English (en)
Inventor
Evangelos Karavas
Efthimios Koutris
Vasiliki Samara
Ioanna Koutri
Anastasia Kalaskani
Andreas Kakouris
Original Assignee
Pharmathen Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmathen Sa filed Critical Pharmathen Sa
Publication of HUE051902T2 publication Critical patent/HUE051902T2/hu

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A61K31/381—Heterocyclic compounds having sulfur as a ring hetero atom having five-membered rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2886—Dragees; Coated pills or tablets, e.g. with film or compression coating having two or more different drug-free coatings; Tablets of the type inert core-drug layer-inactive layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4808—Preparations in capsules, e.g. of gelatin, of chocolate characterised by the form of the capsule or the structure of the filling; Capsules containing small tablets; Capsules with outer layer for immediate drug release
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
HUE14718330A 2013-04-23 2014-04-17 Duális újrafelvétel inhibitort tartamazó gyógyászati készítmény és eljárás annak elõállítására HUE051902T2 (hu)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GR20130100262A GR1008228B (el) 2013-04-23 2013-04-23 Φαρμακευτικο σκευασμα περιεχον ενα διπλο αναστολεα επαναπροσληψης και μεθοδος για την παρασκευη αυτου

Publications (1)

Publication Number Publication Date
HUE051902T2 true HUE051902T2 (hu) 2021-03-29

Family

ID=50513884

Family Applications (1)

Application Number Title Priority Date Filing Date
HUE14718330A HUE051902T2 (hu) 2013-04-23 2014-04-17 Duális újrafelvétel inhibitort tartamazó gyógyászati készítmény és eljárás annak elõállítására

Country Status (7)

Country Link
EP (1) EP2988735B1 (hu)
DK (1) DK2988735T3 (hu)
ES (1) ES2814965T3 (hu)
GR (1) GR1008228B (hu)
HU (1) HUE051902T2 (hu)
PL (1) PL2988735T3 (hu)
WO (1) WO2014173516A1 (hu)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2019081753A (ja) * 2017-10-30 2019-05-30 大原薬品工業株式会社 デュロキセチン塩酸塩の溶出性が改善された腸溶性製剤
US20220202771A1 (en) * 2019-04-05 2022-06-30 University Of North Texas Health Science Center At Fort Worth Antidepressants for the Treatment or Prevention of Memory Loss and/or Cognitive Decline or Dysfunction in Aging
JP2020189815A (ja) * 2019-05-23 2020-11-26 東和薬品株式会社 デュロキセチン製剤およびその安定化方法
WO2021126098A1 (en) * 2019-12-18 2021-06-24 Santa Farma İlaç Sanayi̇ A.Ş. Gastro-resistant pellet comprising duloxetine

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5508276A (en) * 1994-07-18 1996-04-16 Eli Lilly And Company Duloxetine enteric pellets
WO2007034503A2 (en) * 2005-06-20 2007-03-29 Cadila Healthcare Limited Controlled release dosage formulation of duloxetine
US20060165776A1 (en) * 2005-08-31 2006-07-27 Ramesh Sesha Antidepressant oral pharmaceutical compositions
MX2009007057A (es) * 2006-12-27 2009-09-23 Lek Pharmaceuticals Composicion de duloxetina.
US9358213B2 (en) * 2007-04-20 2016-06-07 Wockhardt Limited Pharmaceutical compositions of duloxetine
US20110070299A1 (en) * 2008-01-25 2011-03-24 Alphapharm Pty Ltd. Delayed release pharmaceutical composition of duloxetine
US20090226517A1 (en) * 2008-02-06 2009-09-10 Vinita Umashankar Vyas Pharmaceutical formulations comprising duloxetine
AU2009230676A1 (en) * 2008-03-24 2009-10-01 Lupin Limited Delayed release compositions of duloxetine
US20100040680A1 (en) * 2008-08-15 2010-02-18 Felix Lai Multiparticulate selective serotonin and norepinephrine reuptake inhibitor formulation
CN101756960B (zh) * 2008-12-26 2012-06-27 上海中西制药有限公司 一种度洛西汀肠溶制剂及其芯材和制备方法

Also Published As

Publication number Publication date
EP2988735B1 (en) 2020-06-24
DK2988735T3 (da) 2020-08-31
WO2014173516A1 (en) 2014-10-30
GR1008228B (el) 2014-06-16
EP2988735A1 (en) 2016-03-02
PL2988735T3 (pl) 2021-03-08
ES2814965T3 (es) 2021-03-29

Similar Documents

Publication Publication Date Title
PT3030262T (pt) Composição farmacêutica de associação
IL246377A0 (en) Pharmaceutical preparations for oral administration
EP2815746A4 (en) SAPONIN NANOMIZELES, MANUFACTURING METHOD, APPLICATION THEREOF AND PHARMACEUTICAL COMPOSITION THEREOF
HK1213182A1 (zh) 外用藥物組合物
EP2990038A4 (en) SOLID PHARMACEUTICAL COMPOSITION
EP2990039A4 (en) Solid pharmaceutical composition
ZA201507717B (en) Composition comprising salbutamol sulphate
EP3037099A4 (en) Pharmaceutical composition, preparation method therefor and use thereof
SG11201601477VA (en) Pharmaceutical composition
HK1219691A1 (zh) 醫藥組成物及其用途
GB201320932D0 (en) Topical pharmaceutical composition
PL2988735T3 (pl) Kompozycja farmaceutyczna zawierająca inhibitor wychwytu zwrotnego o podwójnym działaniu i sposób jego wytwarzania
ZA201600027B (en) Pharmaceutical preparation
EP3078659A4 (en) 3-FURYL-2-CYANO-2-ACRYLAMIDE DERIVATIVE, PROCESS FOR PREPARING THE SAME, PHARMACEUTICAL COMPOSITION AND USE THEREOF
HK1220143A1 (zh) 藥物組合物
HK1216840A1 (zh) 包含右酮洛芬和曲馬多的藥物組合物
EP2992890A4 (en) Pharmaceutical composition
ZA201303193B (en) Pharmaceutical composition comprising a dual reuptake inhibitor and method for the preparation thereof
ZA201506465B (en) Pharmaceutical preparation
ZA201503860B (en) Pharmaceutical composition comprising atomoxetine and method for the preparation thereof
GB201304625D0 (en) New pharmaceutical composition
ZA201302189B (en) Pharmaceutical composition comprising a fluoroquinolone antibacterial agent and method for the preparation thereof
AU2013903813A0 (en) Pharmaceutical composition